CD8A and neoplasm: The therapeutic effects of B16-mBD2 vaccination were likely mediated by vaccine-induced strong pro-inflammatory NK and T cell immunity, particularly for CD8+ T cell responses, high levels of IFN-γ and IL-12 production and massive CD8+ and CD4+ T cell, NK and macrophage infiltration in the tumor tissues.